These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38865863)

  • 1. Preconditions for efficiency and affordability in competitive healthcare markets: Are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland? Ten years later.
    van de Ven WPMM; Beck K; Buchner F; Schokkaert E; Schut FT; Shmueli A; Wasem J
    Health Policy; 2024 Aug; 146():105099. PubMed ID: 38865863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preconditions for efficiency and affordability in competitive healthcare markets: are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland?
    van de Ven WP; Beck K; Buchner F; Schokkaert E; Schut FT; Shmueli A; Wasem J
    Health Policy; 2013 Mar; 109(3):226-45. PubMed ID: 23399042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consumer mobility in social health insurance markets : a five-country comparison.
    Laske-Aldershof T; Schut E; Beck K; Gress S; Shmueli A; Van de Voorde C
    Appl Health Econ Health Policy; 2004; 3(4):229-41. PubMed ID: 15901197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk adjustment and risk selection in Europe: 6 years later.
    van de Ven WP; Beck K; Van de Voorde C; Wasem J; Zmora I
    Health Policy; 2007 Oct; 83(2-3):162-79. PubMed ID: 17270311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statutory health insurance competition in Europe: a four-country comparison.
    Thomson S; Busse R; Crivelli L; van de Ven W; Van de Voorde C
    Health Policy; 2013 Mar; 109(3):209-25. PubMed ID: 23395277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk adjustment and risk selection on the sickness fund insurance market in five European countries.
    van de Ven WP; Beck K; Buchner F; Chernichovsky D; Gardiol L; Holly A; Lamers LM; Schokkaert E; Shmueli A; Spycher S; Van de Voorde C; van Vliet RC; Wasem J; Zmora I
    Health Policy; 2003 Jul; 65(1):75-98. PubMed ID: 12818747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some aspects of the reform of the health care systems in Austria, Germany and Switzerland.
    Theurl E
    Health Care Anal; 1999; 7(4):331-54. PubMed ID: 10787796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of federalism on the healthcare system in terms of efficiency, equity, and cost containment: the case of Switzerland.
    Crivelli L; Salari P
    Dev Health Econ Public Policy; 2014; 12():155-78. PubMed ID: 24864386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supervision in social health insurance: a four country study.
    Maarse H; Paulus A; Kuiper G
    Health Policy; 2005 Mar; 71(3):333-46. PubMed ID: 15694500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing the health care market in developing countries: prospects and problems.
    Broomberg J
    Health Policy Plan; 1994 Sep; 9(3):237-51. PubMed ID: 10137740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-care expenditure and health policy in the USA versus other high-spending OECD countries.
    Lorenzoni L; Belloni A; Sassi F
    Lancet; 2014 Jul; 384(9937):83-92. PubMed ID: 24993914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How can the regulator show evidence of (no) risk selection in health insurance markets? Conceptual framework and empirical evidence.
    van de Ven WP; van Vliet RC; van Kleef RC
    Eur J Health Econ; 2017 Mar; 18(2):167-180. PubMed ID: 26837411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconsidering the Role of Competition in Health Care Markets. Proceedings of an international conference. Berlin, Germany, May 1998.
    J Health Polit Policy Law; 2000 Oct; 25(5):863-978. PubMed ID: 11068730
    [No Abstract]   [Full Text] [Related]  

  • 14. Hospital merger control in Germany, the Netherlands and England: Experiences and challenges.
    Schmid A; Varkevisser M
    Health Policy; 2016 Jan; 120(1):16-25. PubMed ID: 26643437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Managed competition in the health-care services - the Dutch experience].
    Ahrens D
    Gesundheitswesen; 2013 Jun; 75(6):386-92. PubMed ID: 23172597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has solidarity survived? A comparative analysis of the effect of social health insurance reform in four European countries.
    Maarse H; Paulus A
    J Health Polit Policy Law; 2003 Aug; 28(4):585-614. PubMed ID: 12956517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competition policy for health care provision in Germany.
    Kifmann M
    Health Policy; 2017 Feb; 121(2):119-125. PubMed ID: 27908564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public healthcare interests require strict competition enforcement.
    Loozen EM
    Health Policy; 2015 Jul; 119(7):882-8. PubMed ID: 25739723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preconditions for efficiency and affordability in mixed health systems: are they fulfilled in the Australian public-private mix?
    Berardi C; Arija Prieto P; Henríquez J; Paolucci F
    Health Econ Policy Law; 2024 Jan; ():1-16. PubMed ID: 38264962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demand-side strategies to deal with moral hazard in public insurance for long-term care.
    Bakx P; Chernichovsky D; Paolucci F; Schokkaert E; Trottmann M; Wasem J; Schut F
    J Health Serv Res Policy; 2015 Jul; 20(3):170-6. PubMed ID: 25770020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.